NMS Group
Daniela Monticelli is an experienced Quality Assurance Manager at NMS Group - Nerviano Medical Sciences since January 2020, following a tenure as Head of Quality Assurance at Clioss from November 2012 to January 2020. Daniela has a robust background in quality management systems and compliance, having also held roles such as Head of Project Management and Head of Clinical Project Management in previous positions. With a career spanning over two decades, Daniela has demonstrated expertise in clinical trial management, including site selection and monitoring compliance in the hematology and oncology domains. Previous experience includes roles at Farma Resa CRO and Farma Resa s.r.l., focusing on clinical project coordination and monitoring. Daniela holds a Laurea in Pharmaceutical Chemistry and Technology from Università degli Studi di Milano.
This person is not in any teams
This person is not in any offices
NMS Group
NMS Group S.p.A. is the largest company in Italy committed in innovation and oncology R&D. With 420 total employees, NMS Group employs over 200 qualified researchers involved in research and development, from 'target validation' to phase II clinical trials. NMS Group S.p.A. is the only company in Italy able to manage the entire integrated chain of the research and development path: from pre-clinical phase of research, to First-Time-In-Man of clinical phase, up to production and packaging of the finished drug. The Group also provides services of Research and Production addressed to local and international markets through three different companies: Accelera, one of the few companies engaged in preclinical research in Italy; Clioss engaged in clinical development starting from First-Time-In-Man and Nerpharma, dealing with activities from formulation to production of the active principle.